Table 2.
Lesion-related preoperative parameters of the study population
| Variables | Proliferative phase (n = 80) |
Secretory phase (n = 63) |
P value |
|---|---|---|---|
| Preoperative pretreatment | 10 (12.5%) | 16 (25.4%) | 0.047* |
| Serum CA125 (U/ml) | 110.77 ± 115.18 (n = 74) | 98.48 ± 71.08 (n = 54) | 0.693 |
| Lesion location | 0.622 | ||
| Uterine fundus | 10 (12.5%) | 6 (9.5%) | |
| Anterior uterine wall | 19 (23.8%) | 12 (19%) | |
| Posterior uterine wall | 51 (63.7%) | 45 (71.4%) | |
| Maximum uterine diameter on ultrasound (cm) | 8.14 ± 1.93 (n = 74) | 8.19 ± 1.83 (n = 57) | 0.882 |
| Maximum lesion diameter on ultrasound (cm) | 5.36 ± 1.79 (n = 75) | 5.16 ± 1.57 (n = 61) | 0.484 |
| Maximum lesion diameter on MRI (cm) | 4.73 ± 1.56 (n = 69) | 4.99 ± 1.80 (n = 57) | 0.395 |
The values are presented as mean ± standard or number (percentage)
*P < 0.05, **P < 0.01, ***P < 0.001